Netherlands buys Cervarix
This article was originally published in Scrip
Executive Summary
GlaxoSmithKlinewill supply its cervical cancer vaccine Cervarix to the Dutch national immunisation programme, which aims to vaccinate all 12-year-old girls. A catch-up programme for girls aged 13-16 will begin next year. GSK estimates that 350,000 girls will be vaccinated with Cervarix in the first year.